Anton G. Gueth

Anton G. Gueth

Algemeen Directeur bij
Evolution Life Science Partners
69 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Anton G.
Gueth
is currently the Joint Managing Director at Evolution Life Science Partners since 2014 and the President & Managing Partner at Gueth Consulting LLC since 2003.
Previously, he served as the Chairman at Navidea Biopharmaceuticals, Inc. in 2016, Director-Alliance Management at Eli Lilly & Co., and Independent Director at Antares Pharma, Inc. from 2003 to 2022.
He also held positions as an Independent Director at Spectrum Pharmaceuticals, Inc. in 2012-2013, Director-Northern California Chapter at American Liver Foundation, Independent Director at Elevar Therapeutics, Inc., Director at Eqinox Healthcare France SASU, and Managing Director at Burrill Securities LLC.
Additionally, he served as the Managing Director-Gulf & Yemen Operations at Eli Lilly Saudi Arabia Ltd. and as a Director at iQone Healthcare Holding in 2012-2013.
Mr. Gueth also held positions as Vice President-Financial Planning & Treasury at PCS Health Systems, Inc. and Vice President-Business Development at NewBridge Pharmaceuticals FZ LLC.
He holds graduate degrees from Indiana University and the University of Giessen.

Actieve functies van Anton G. Gueth

BedrijvenFunctieBegin
President 01-01-2003
Algemeen Directeur 01-10-2014

Eerdere bekende functies van Anton G. Gueth

BedrijvenFunctieEinde
ANTARES PHARMA, INC. Directeur/Bestuurslid 24-05-2022
NAVIDEA BIOPHARMACEUTICALS, INC. Voorzitter 31-03-2016
SPECTRUM PHARMACEUTICALS, INC. Directeur/Bestuurslid 28-06-2013
Directeur/Bestuurslid 01-06-2013
Directeur/Bestuurslid -
Ervaring van Anton G. Gueth in detail bekijken

Opleiding van Anton G. Gueth

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

57

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit16

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Finance

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Anton G. Gueth
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU